US Stock Futures Edge Higher Ahead Of Tiffany Earnings - Bristol-Myers Squibb (NYSE:BMY)

Pre-open movers

US stock futures traded slightly higher in early pre-market trade, ahead of earnings from Tiffany & Co

TIF

. Futures for the Dow Jones Industrial Average surged 15 points to 17,112.00, while the Standard & Poor's 500 index futures rose 0.70 points to 1,999.30. Futures for the Nasdaq 100 index climbed 2.25 points to 4,074.50.

A Peek Into Global Markets

European markets were mixed today, with the Spanish Ibex Index rising 0.25%, STOXX Europe 600 Index gaining 0.11%. German DAX 30 index dropped 0.13%, French CAC 40 Index declined 0.14% and London's FTSE 100 Index gained 0.06%. French business confidence declined to 96 in August, versus 97 in July. In Asian markets, Japan's Nikkei Stock Average rose 0.09%, Hong Kong's Hang Seng Index declined 0.62%, China's Shanghai Composite Index gained 0.11% and India's Sensex gained 0.44%.

Broker Recommendation

Analysts at UBS upgraded Aruba Networks

ARUN

from Neutral to Buy. The target price for Aruba Networks has been raised from $21 to $25. Aruba Networks' shares surged 8.70% to $22.00 in pre-market trading.

Breaking news

Kulicke and Soffa Industries KLIC today announced its Board of Directors has authorized the repurchase of up to $100 million of the Company's common shares. To read the full news, click here.
Lakes Entertainment LACO announced that it has retained the services of Macquarie Capital as its financial advisor in connection with its evaluation of strategic alternatives aimed at enhancing shareholder value. To read the full news, click here.
Procera Networks PKT today announced $5 million in initial orders from a Tier 1 European MSO that represents the second largest initial customer orders in company history. To read the full news, click here.
Bristol-Myers Squibb BMY today announced that the European Commission has approved Daklinza (daclatasvir), a potent, pan-genotypic NS5A replication complex inhibitor (in vitro), for use in combination with other medicinal products across genotypes 1, 2, 3 and 4 for the treatment of chronic hepatitis C virus (HCV) infection in adults. To read the full news, click here.

Market News and Data brought to you by Benzinga APIs